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ABSTRACT
Objectives: Vaccination is the most effective method of controlling influenza in the human population, where pregnant 
women belong to a risk group that is especially vulnerable to influenza-related morbidity and mortality. The objectives of 
the survey were to report estimates of maternal vaccination coverage and assess reasons for the lack of influenza vaccina-
tion among Polish women of childbearing age. 
Material and methods: The survey analysis included 564 pregnant women who had been surveyed in a self-reported 
questionnaire during the 2017–2018 influenza season in Warsaw, Poland. 
Results: Over 95% of Polish women of childbearing age did not vaccinate against influenza due to the low perception 
of risk and a lack of providing evidence-based information on vaccine by physicians and midwives. General practitioners 
were most often indicated as healthcare workers who educated women about influenza risk factors and recommended 
influenza vaccine to them. 
Conclusions: The results of the survey suggest that women of childbearing age did not vaccinate against influenza 
due to the low perception of risk and a lack of providing evidence-based information by healthcare workers (including 
obstetrician-gynaecologists and midwives), while their recommendations appear to be a powerful method of overcoming 
barriers to influenza vaccination among patients.
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INTRODUCTION
Due to low influenza vaccination coverage (IVC), influen-
za constitutes one of the major health problems worldwide. 
While the main factor of low ICV in low and middle income 
countries is poverty, in high income countries it is related 
to poor knowledge of influenza complications and protec-
tive impact of vaccination for population health, along with 
high activity of anti-vaccination movements, resulting in the 
increase of vaccine hesitancy and refusals [1]. The influenza 
vaccine is one of the most important vaccines recommend-
ed in communicable disease prevention. This particularly 
concerns pregnant women, who are more prone to severe 
influenza, which is associated with hospitalization or death, 
increased risk of preterm births and low birth weight as well 
as an increased risk of hospitalization or death in the first six 
months of infant life [2, 3]. The World Health Organization 
(WHO) have classified pregnant women as the group of high-
est priority for seasonal influenza vaccination programs since 
2012 [4]. Pregnancy might be an opportunity for healthcare 
providers (HCPs) to advocate for appropriate vaccination due 
to consistent contact with pregnant patients [5].
Objectives
The objectives of the analysis were to estimate maternal 
IVC and assess reasons for non-vaccination against influenza 
among Polish women of childbearing age. 
MATERIAL AND METHODS
Setting and population
The survey was carried out in the 2nd Department of 
Obstetrics and Gynaecology, Medical University of Warsaw 
(MUW), a tertiary unit within the Polish National Health Insur-
ance System. In 2017, the Department was one of 8 tertiary 
Obstetrics and Gynaecology units in Masovian voivodeship, 
providing public healthcare to the population of approxi-
mately 1 186 000 women of childbearing age (19–49 years) [6]. 
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Survey design
An original questionnaire was designed to establish 
main factors behind women of childbearing age getting vac-
cinated or not against influenza in the 2016–2017 (pre-preg-
nancy) and 2017–2018 (pregnancy) influenza seasons. The 
survey was anonymous and distributed during the 2017– 
–2018 season. The responses were kept in secure data stor-
age. Self-reported data included age, birth rate, noncom-
municable diseases, gestational diabetes and vaccination 
status.
Inclusion criteria and recruitment
Women that were pregnant 9 weeks or more were eli-
gible for inclusion. Information about the survey was dis-
tributed by obstetric providers among patients of the 2nd 
Department of Obstetrics and Gynaecology, MUW. Verbal 
invitation to participate in the study was issued by the ob-
stetric providers, including the authors, within the context 
of a routine clinical care
Ethical approval
Ethical approval of the survey was granted by the MUW 
Ethics Committee (AKBE/160/17). Participants were pro-
vided a patient information form with the presentation of 
the aims of the study. It was emphasized that participation 
was voluntary and would have no implications for the an-
tenatal care of the patients. The decision to participate or 
not was left to the patients in the absence of the authors 
of the survey.
Statistical analyses
Statistical analyses were performed using the statisti-
cal program Statistica 13. Quantitative variables had been 
checked for their data distribution before the analysis. The 
statistically significant results were at the p < 0.05. The 
Mann-Whitney’s U-test and Pearson chi-square analysis were 
used to analyse the results. While assessing participants’ 
knowledge, the answers “definitely yes” and “rather yes” were 
found to be correct, except questions about contraindica-
tions to vaccination, in which “definitely no” and “rather no” 
were correct answers.
RESULTS
Pregnant patients were asked about their opinions and 
practices related to influenza illness and vaccination.
The questionnaire was completed by 564 eligible 
women. Over 54% of participants were aged between 31– 
–40 years (Fig. 1). Most patients declared having a higher ed-
ucation degree (64.9%) (Fig. 2). Similar percentage of women 
declared it was their first or second pregnancy (38.1% vs 
36.2% respectively) (Fig. 3). Pregnancies were planned in 
85.1%. Complications of pregnancy were reported by 75.4% 
Figure 1. Percentage of participants by age (n = 564)
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Figure 2. Percentage of participants by education level (n = 564)
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Figure 3. Percentage of women by the number of pregnancies (n = 564)
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of patients, of which gestational diabetes was predominant 
(76.6%); whereas 17.7% women declared uncomplicated 
pregnancies, and no information about pregnancy status 
was indicated by 6.9% participants.
IVC declared in the 2016–2017 (pre-pregnancy) sea-
son was at the level of 2.8%, whereas 1.8% of participants 
did not remember their vaccination status in that season. 
Regular influenza vaccination was declared by the same 
percentage of women (2.8%). Occasional vaccination was 
declared by 16.9%. Only 3.5% of pregnant patients declared 
their willingness to be vaccinated against influenza in the 
upcoming 2017–2018 season, while 68.0% of them were 
strongly opposed to it, and 28.5% were hesitant. There was 
no statistically significant difference between women with 
uncomplicated and complicated pregnancies in the ap-
proach to influenza vaccination (p = 0.8340).
The analysis of patients’ knowledge of influenza illness 
and vaccination showed that a low percentage of women 
of childbearing age had sufficient information on influenza 
risk factors and complications or influenza vaccines (Tab. 1, 2; 
Fig. 4). Only 0.5% of all women answered all questions cor-
rectly (Fig. 4).
To evaluate responses by age and education level, the 
participants were regrouped, as the number of women aged 
over 40 and those with the primary education were small 
(they were combined with women aged 31–40 and those 
with the secondary education, respectively).
A detailed analysis of data showed statistically significant 
differences in answers to 11 questions on the knowledge of 
influenza risk factors and vaccination in pregnant women 
with regard to their education level (p = 0.0059) (Tab. 3; 
Fig. 5); however, no differences were found with regard to 
the age of patients (Tab. 4).
Over 60% of participants reported the Internet as the main 
source of information on influenza and influenza vaccination, 
followed by general practitioners (GPs), media other than the 
Internet, family and friends as other sources of information 
(Fig. 6, 7). A detailed analysis by age and education level showed 
statistically significant differences in sources of information on 
influenza illness (Fig. 8, 9) and vaccination (Fig. 10, 11).
Table 1. Knowledge of the risk factors related to severe and complicated influenza among women of childbearing age (correct answer in bold type)
Question
Answer (%, N)
Definitely yes Rather yes I don’t know Rather no Definitely no
1. Do you think that pregnancy and postpartum period are 











2. Do you think that chronic pulmonary diseases are risk 











3. Do you think that metabolic diseases, including diabetes, 











4. Do you think that overweight and obesity are risk factors 











5. Do you think that the flu is a dangerous disease with the 
risk of complications for pregnant women and postpartum 











6. Do you think that the flu is a dangerous disease with the 











Table 2. Knowledge about influenza vaccination among women of childbearing age (correct answer in bold type)
Question
Answer {%, (N)}
Definitely yes Rather yes I don’t know Rather no Definitely no
7. Do you think that flu vaccination is safe for pregnant 











8. Do you think that flu vaccination is effective for pregnant 











9. Do you think that flu vaccination is necessary for pregnant 











10. Do you think that pregnancy and postpartum period are 











11. Do you think that lactation is contraindication for flu 
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M — median; *U Mann-Whitney test
Figure 4. Percentage of answers given by women of childbearing age that were correct with regard to influenza risk factors and vaccination



























































Primary and secondary education
Higher education
39
Anna M. Jagielska et al., Influenza vaccination among women in PL
www. journals.viamedica.pl/ginekologia_polska




p value*18–30 years > 30 years Total
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M — median; *U Mann-Whitney test
Figure 6. Sources of information on influenza illness (multiple-choice question) (n = 555)
































Figure 7. Sources of information on influenza vaccination (multiple-choice question) (n = 545)
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Figure 8. Sources of information on influenza illness by age group (multiple-choice question) (n = 554)
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Figure 9. Sources of information on influenza illness by education group (multiple-choice question) (n = 550)
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Figure 10. Sources of information on influenza vaccination by age group (multiple-choice question) (n = 544) 
Figure 11. Sources of information on influenza vaccination by education group (multiple-choice question) (n = 540)
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Figure 12. Reasons for vaccine refusal among pregnant women (n = 432)
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Main reasons for refusing influenza vaccination were 
negative attitude towards vaccination (conviction that it is 
unnecessary, ineffective or dangerous for pregnant women), 
a belief that influenza was a rare disease and lack of vaccina-
tion refund (Fig. 12).
DISCUSSION
In the study, self-reported IVC rates were estimated and 
potential determinants of influenza vaccination uptake were 
examined (including sociodemographic factors, obstetric 
characteristics, maternal health beliefs and sources of infor-
mation on influenza illness and vaccination) in the group of 
women of childbearing age in a single obstetric care centre 
in Warsaw, the capital of Poland. 
Self-reported IVC in the survey was ca. 3%. A similar 
percentage of participants declared their willingness to 
get vaccinated against influenza during pregnancy in the 
upcoming influenza season; however, almost 70% of partici-
pants were strongly opposed to the vaccination. For many 
years, IVC in Poland has been very low and remained below 
4% [7, 8]. IVC among the survey participants was compa-
rable to the general population and much lower than that 
reported in other countries. In comparison to our survey, 
self-reported IVC rates among pregnant women in the pre-
vious and subsequent influenza seasons in other countries 
were as follows: 50–78% in the USA [9–13], ca. 50% in Aus-
tralia [14], 45% in Belgium [15], 11–23% in Germany [16], less 
than 10% in France and Singapore [17, 18]. Regular influ-
enza vaccination in previous years increased the probability 
of influenza immunization during pregnancy as much as 
4 times [9] or at least it provided a similar level of IVC [12, 19], 
which has also been observed in our study: 3.5% of preg-
nant participants wanted to vaccinate in the upcoming 
2017–2018 season, as compared with the observed 2.8% 
IVC in the 2016–2017 season.
Polish women of childbearing age had insufficient 
knowledge of influenza risk factors and vaccination, which 
has been identified as patient barriers to vaccination of 
the same importance as negative vaccination history, gen-
eral mistrust towards the medical establishment, lack of 
established relationship with obstetrician-gynaecologists 
(OB/GYNs) as vaccine providers and no access to medi-
cal care [12]. Less than 5% of pregnant participants to the 
study gave correct answers to 8 or more out of 11 questions 
about influenza risk factors and vaccination; over 50% of 
patients provided less than 4 correct answers. Knowledge of 
influenza vaccination was poorer than that of the influenza 
risk factors. These results were worse than those observed 
by Kuchar E. et al. [7] for the general Polish population in 
2018 and those obtained in the unvaccinated US pregnant 
female population [20]. Women with a higher level of edu-
cation had a statistically significant better knowledge of 
risk factors, in particular, and according to some authors, 
higher level of education had a significant influence on 
the maternal IVC [15, 20, 21]. The majority of the surveyed 
women searched for the information on influenza illness and 
vaccination on the Internet (64.5% and 58.9% respectively), 
with a statistically significant difference with regard to the 
level of education: patients with higher education chose the 
Internet as the source of information on influenza illness and 
vaccination (68.3%), and they used TV, radio and newspapers 
as a source of information on influenza illness (44.2%) and 
vaccination (43.3%). A systematic review of the Internet use 
among pregnant women revealed that the Internet was rec-
ognized in many countries to be a reliable and useful source 
of information about pregnancy and birth: up to 75% of 
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childbearing women used it to deal with pregnancy-related 
doubts and decisions, whereby better educated women 
were three times more likely to seek advice online than those 
less educated [22]. Unfortunately, up to 70% of women did 
not discuss the information found online with their HCPs 
[20], which is why “HCPs may not be aware of potentially 
inaccurate information or mistaken beliefs about pregnancy, 
reported on the Internet”, as Sayakhat et al. [22] aptly put it. 
Influenza vaccination in pregnancy was included into 
the Polish National Immunisation Programme in 2014 as 
it was first recommended by the WHO in 2012 [4, 23]. The 
Programme is conducted by GPs in children and adults. This 
provides explanation why GPs were the second major source 
of information on influenza illness and vaccination (56.9% 
and 48.3% respectively) and why they were a statistically sig-
nificant, more common source of information on influenza 
vaccination for the better educated participants (p = 0.0137). 
An exceptionally low percentage of pregnant women indi-
cated midwives (< 10%) or physicians (< 5%) as the sources 
of information. A prospective observational hospital-based 
study performed in France in the 2014–2015 season on 
a group of 2045 pregnant women showed a similar per-
centage of vaccine recommendations by GPs (57.3%), but 
a significantly higher percentage of recommendations by 
midwives (40.1 to 54.3%) or physicians (48.1%). GPs ad-
ministered 67.6% of vaccines among pregnant women in 
Belgium [15]. In our study, only 2 pregnant women indi-
cated OB/GYNs as information providers. Almost 10% of 
Spanish pregnant women vaccinated against influenza re-
called being informed about influenza vaccine by their GPs, 
whereas almost 90% declared midwives to be the source 
of information [19]. Bartolo et al. [24] reported that 50.7% 
of French OB/GYNs recommended influenza vaccine in the 
2014–2015 season, which was similar to the data obtained 
in French reports since 2010 (56%) [17]. According to King JP 
et al. [20], in the 2016–2017 season ca. 80% of vaccinated 
or unvaccinated US pregnant women indicated that their 
obstetric providers (OB/GYNs and midwives) frequently 
recommended influenza vaccination. Over 90% of those 
women reported being recommended influenza vaccine by 
at least one HCP and none of them reported being advised 
against vaccination by their HCPs, while in our survey it was 
reported that 2% of Polish physicians advised their patients 
not to vaccinate during pregnancy. Gaps in HCPs’ knowl-
edge about influenza vaccine contributed to low IVC of 
patients, whereas lack of providing vaccination to pregnant 
women by the OB/GYNs resulted from the conviction that 
the influenza vaccine should be administered by GPs [12]. 
Vishram et al. [25] proved that HCPs were more likely to 
recommend influenza vaccination in pregnancy if they had 
been vaccinated as patients or healthcare workers. The ob-
served IVC rates in the Polish HCPs ranged from 10% to 
20% [26, 27], which may result in providing insufficient 
recommendations for influenza vaccination to pregnant 
women. Personal recommendation of HCPs to get vacci-
nated against influenza during pregnancy increased the 
odds ratio of accepting the vaccine from 1.45 to 7 times 
[9, 12, 18]. Pregnant women appeared highly motivated to 
improve their health in order to protect their children [12, 20]. 
If they were offered vaccination by HCPs, they were also 
more likely to have a positive attitude towards vaccine ef-
ficacy and safety [12, 21]. Statically, 50% of French mothers 
and 78% of Kenyan women reported their willingness to 
get vaccinated during their next pregnancy to protect their 
children or prevent a disease [17, 28].
It is worth noticing that good communication between 
HCPs and women of childbearing age, along with influenza 
vaccine recommendations, increased the IVC rates by 80% 
even among patients with a negative attitude towards influ-
enza vaccination [12]. This is particularly crucial for the popu-
lations with extremely low IVC, such as Polish women of 
childbearing age. Over 95% of pregnant participants to the 
study did not get vaccinated in the 2016–2017 and 2017– 
–2018 seasons. Between 15–22% of them believed vaccina-
tion was unnecessary, ineffective or dangerous for pregnant 
women and that influenza was a rare disease, which might 
be related to the observed ignorance of influenza risk factors 
and vaccination. Similar reasons for refusing vaccination 
were found in women in other countries. A comparable per-
centage of unvaccinated Spanish pregnant women underes-
timated the personal risk of contracting influenza (23%) or 
considered the vaccination as non-essential (16%) [19]. Up 
to 30% of US respondents who reported having received no 
influenza vaccine were concerned about vaccine effective-
ness, and the risk of the mother or baby getting influenza 
after the vaccination [12, 20]. It should be stressed that dur-
ing the pandemic of AH1N1pdm09 influenza, no harm to the 
fetus was found in the population of over 31,000 children 
exposed to influenza vaccine while in utero [29]. According 
to a retrospective observational matched-cohort study per-
formed from 2004–2005 to 2008–2009 seasons on a group 
of over 57 000 women, maternal vaccination was not associ-
ated with an increased or decreased risk of preterm or small 
for gestational age birth [30]. Murthy NC et al. [13] observed 
that almost 65% of pregnant women did not know medical 
recommendations for seasonal influenza vaccination at the 
time of the study, and that IVC was higher among women 
who indicated correct maternal influenza vaccination rec-
ommendations (63.4%), as compared to those who did not 
know the correct recommendations (39.7%). The US study 
data also suggested that vaccination offers combined with 
HCP’s recommendations were more likely to result in vac-
cination being performed than the vaccination recommen-
dations alone; increasing IVC from 14.8% to 70.5% [11, 13], 
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whereby the IVC was limited by the cost of vaccine. Over 
8% of Polish women of childbearing age indicated the lack 
of influenza vaccination refund as a reason for refusing 
influenza vaccination in pregnancy. If the vaccination cost 
was covered by the health insurance, IVC could be 2.3 times 
higher [18], therefore high IVC rates are observed in the 
countries where both the vaccine itself and vaccine admin-
istration are covered by the health insurance [8].
CONCLUSIONS
The results of our survey indicate that women of child-
bearing age did not vaccinate against influenza due to the 
low perception of risk and a lack of providing evidence-based 
information by HCPs (GPs, OB/GYNs and midwives). These 
findings highlight the need to improve the performance of 
influenza vaccination promotion activities among pregnant 
patients by HCPs, as their recommendations appear to be 
a powerful method of overcoming barriers to influenza 
vaccination among patients.
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